Impact of Chronic Exposure to Radiofrequency Electromagnetic Fields on Neurophysiological Development in the Preterm Neonate
NeuroPrem-RF
1 other identifier
interventional
40
1 country
1
Brief Summary
The massive use of highly technological devices in Neonatal Intensive Care Units may expose preterm neonates to electromagnetic fields, especially radiofrequencies, at low doses but continuously and chronically. Strikingly, the effect of long-term exposure to radiofrequencies on the neurophysiological development of preterm neonates has never been studied so far. The only studies on the impact of chronic exposure to radiofrequencies have been conducted in animals or adult humans, whereas preterm infants may be particularly vulnerable due to increased penetration of radiofrequency waves into the brain during a crucial period of neurodevelopment. The present project will aim at 1) quantifying individual levels of chronic exposure (during 6 weeks) to which preterm neonates are subjected during their stay in the Neonatal Intensive Care Unit, 2) following the evolution of the thermal environment and of the clinical parameters of the neonates after birth, 3) identifying potential alterations of neurophysiological activity (sleep, cerebral hemodynamics, autonomic nervous activity) which will be correlated to actual levels of chronic RF-EMF (radiofrequency electromagnetic fields) exposure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2019
CompletedFirst Submitted
Initial submission to the registry
April 16, 2019
CompletedFirst Posted
Study publicly available on registry
April 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedMay 10, 2023
May 1, 2023
4.1 years
April 16, 2019
May 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
total sleep time in hours
Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.
from birth to 6 weeks of life
absolute durations of sleep states in hours
Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.
from birth to 6 weeks of life
relative durations of sleep states in hours
Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.
from birth to 6 weeks of life
sleep state change frequency
Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.
from birth to 6 weeks of life
Secondary Outcomes (6)
Cerebral hemodynamics
from birth to 6 weeks of life
Autonomic nervous system activity
from birth to 6 weeks of life
apnea frequency
from birth to 6 weeks of life
bradycardia frequency
from birth to 6 weeks of life
desaturation frequency
from birth to 6 weeks of life
- +1 more secondary outcomes
Study Arms (1)
preterm neonate
EXPERIMENTALInterventions
Parental questionnaire on pregnancy history and environmental exposure
Daily continuous recording of radiofrequency exposure levels (6 weeks) by placing a dosimeter inside the incubator
Follow-up of daily infants environmental and clinical parameters: morphological characteristics, drugs, ventilatory support, dietary management, clinical outcomes, incubator data (temperatures…)
Nocturnal polysomnography (at 3 and 6 weeks of life, between 8 pm and 8 am) with recording of sleep (electroencephalography, electrooculography),
cerebral hemodynamics (near infrared spectroscopy)
activity of the autonomic nervous system (electrocardiography, analysis of heart rate variability)
Eligibility Criteria
You may qualify if:
- preterm neonates born at 26 to 34 weeks of gestational age
- signed written informed consent form
You may not qualify if:
- infants infected
- infants suffering from neurological disorders
- serious heart, respiratory, digestive or metabolic diseases
- infants born from mothers aged less than 18 years old or deprived of their parental rights
- non covered by national health insurance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens
Amiens, 80054, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre Tourneux, Pr
CHU Amiens
- PRINCIPAL INVESTIGATOR
François Moreau, MD
CHU Amiens
- PRINCIPAL INVESTIGATOR
Lucie Aimée Razafimanantsoa, MD
CHU Amiens
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2019
First Posted
April 26, 2019
Study Start
April 1, 2019
Primary Completion
May 1, 2023
Study Completion
August 1, 2023
Last Updated
May 10, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share